Work

Adiponectin Versus Thiazolidinediones and Angiotensin Receptor Blockers

Year: 2013

Type: article

Abstract: Adipose tissue has gained great attention during the last decade. It represents not only a depot for energy stores, but also releases adipocytokines regulating energy disposal and can therefore be considered from therapeutic point of view. Hypoadiponectemia is an independent threat for development of metabolic syndrome. When subjects treated with antidiabetic (Thiazolidinediones) and antihypertensive (angiotensin receptor blocker) agents, the plasma concentration of adiponectin, the only component of adipocytokines, directly proportional to plasma values of these drugs. The prevalance of hypertension and T2DM is mounting with unprecedented degree in both developing and advanced countries, therefore, there is a dire need to find safer and economical therapeutic regimes for the treatment of these ailments, and intensive research is also

Authors: Sheryar Afzal, Munavvar Abdul Sattar, Hassaan Anwer Rathore, Abdullah Ijaz Hussain, Ashfaq Ahmad, Aqeel Javeed, Fiaz-ud-Din Ahmad, Edward J. Johns, Safia Akhtar

Institutions: Universiti Sains Malaysia, Government College University, Faisalabad, University of Veterinary and Animal Sciences, University College Cork

Language: English

Topic: Adipokines, Inflammation, and Metabolic Diseases

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W1514611339

FWCI: 0.204

Cites: 150

Cited by: 1

Related to: 10